Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P238
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Petersen, Christopher
Li, Jian-Ming
Waller, Edmund
Article History
First Online: 4 November 2015